跳至主要内容
临床试验/NCT02002546
NCT02002546已完成不适用

Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction

Chattanooga-Hamilton County Hospital Authority1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
240
试验地点
1
主要终点
Change in Troponin value over a two hour interval.

研究概览

简要总结

  1. In chest pain patients with suspected acute coronary syndrome, a 2-hr delta Troponin-I as measured by the i-STAT immunoassay reliably identifies and excludes an acute myocardial infarction.
  2. In chest pain patients with suspected acute coronary syndrome whose baseline troponin is above the 99th percentile but less than 0.2ng/ml, a 2hr delta Troponin-I as measured by the i-STAT immunoassay accurately discriminates between acute myocardial infarction and non-acute myocardial infarction troponin elevations.

详细描述

Primary Aims: 1) Demonstrate that a 2hr delta troponin as measured by the i-STAT platform can reliably identify and exclude MI on the initial ED evaluation. 2)Demonstrate that a 2hr delta troponin is useful in the discrimination AMI versus non-AMI conditions in patients with low abnormal baseline Troponin-I values.

Secondary Aims: 1) Demonstrate that a positive 2-hr delta troponin-I identifies patients at highest risk for 30 day ACE. 2) Other Secondary aims TBD.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients 18 years of age or older
  • Chest pain suspicious for ACS
  • Absence of ST-segment elevation AMI (STEMI) or STEMI equivalent on the initial ECG
  • Baseline i-STAT troponin less or equal to 1.0 ng/ml
  • Enrollment initiated before 2 hour 'delt' troponin value available for review
  • Ability and willingness to participate and cooperate with telephone follow-up evaluations

排除标准

  • ST-elevation or other ECG criteria that results in the diagnosis of AMI and results in patient being sent for percutaneous coronary interventions (PCI) or being treated with thrombolytics
  • Patients with chest pain not deemed to warrant cardiac screening
  • Blunt chest trauma
  • Tachyarrhythmia (ventricular tachycardia, supraventricular tachycardia, or rapid atrial fibrillation)
  • Cardiac Arrest prior to arrival
  • Hemodynamically unstable patients
  • Pulmonary edema requiring CPAP, BIPAP, or mechanical ventilation
  • Baseline i-STAT troponin measurement greater than 1.0 ng/ml
  • Baseline and 2-hour i-STAT Troponin measurements not obtained
  • Patient (or Legal Representative) unable or unwilling to provide written informed consent
  • Subject unwilling or unlikely to comply with study procedures, including protocol-specific blood sampling
  • Subject unwilling, unable, or deemed unlikely to respond or participate in telephone follow-up
  • Vulnerable populations as deemed inappropriate for the study

结局指标

主要结局

Change in Troponin value over a two hour interval.

时间窗: 2 hours after baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验